Antimicrobial activity against Helicobacter pylori of nine strains of Lactobacillus plantarum isolated from goat cheese produced in the region of Coquimbo, north of Chile
Helicobacter pylori is an infectious agent associated with gastrointestinal diseases. There are several reports about the use of probiotics strains with antimicrobial activity, as treatment to eradicate H. pylori.
EFFECT OF Helicobacter pylori ERADICATION IN METHYLATION ON CDH1 AND CDKN2A PROMOTERS
Helicobacter pylori is the main risk factor for gastric cancer. It is multifactorial process in which interact microorganism, genetic and epigenetic factors.
Helicobacter pylori and Helicobacter cinaedi infection in patients with cardiovascular disease
Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality worldwide. It is estimated that 75% of deaths occur in developing countries.
REPRIMO-LIKE, A NEWLY IDENTIFIED REPRIMO PARALOGUE GENE, IS DOWNREGULATED BY DNA METHYLATION IN EARLY GASTRIC CANCER
Reprimo (RPRM) is a tumor suppressor gene, frequently silenced by DNA methylation during advanced stages of gastric cancer (GC). Loss of expression of RPRM in GC has been associated to increased invasiveness and poor prognosis.
Epithelial barrier disruption and gastric cancer signaling by Helicobacter Pylori
The Helicobacter pylori type IV secretion system (T4SS) encoded by the cag pathogenicity island forms needle-like pili, whose binding to the integrin-β1 receptor results in injection of the CagA oncoprotein.
REPRIMO EXPRESSION IN GASTRIC CANCER AND OLGA AND OLGIM STAGES
astric cancer (GC) is the third leading cancer-related cause of death worldwide, being the Andean region of Latin America a high-risk zone.